PMID- 1328826 OWN - NLM STAT- MEDLINE DCOM- 19921119 LR - 20190819 IS - 0385-5600 (Print) IS - 0385-5600 (Linking) VI - 36 IP - 4 DP - 1992 TI - Antiviral activity of a bile pigment, biliverdin, against human herpesvirus 6 (HHV-6) in vitro. PG - 381-90 AB - Biliverdin (BV), a bile pigment, was examined for its antiviral activity against human herpesvirus-6 (HHV-6) in vitro. BV (10 micrograms/ml) markedly inhibited HHV-6 replication in MT-4 cells when the cells were treated during a virus adsorption period. Its antiviral effect was weakened when cells were treated after adsorption. Treatment of cells with BV (40 micrograms/ml) 3 hr after virus infection had no inhibitory effect on virus replication. Virus replication was also significantly inhibited by treatment of MT-4 cells with BV (10 micrograms/ml) before infection, while the virions were not inactivated by BV (20 micrograms/ml). Bilirubin and urobilin, metabolic derivatives of BV, showed slight inhibitory effects on virus replication in the cells. On the other hand, BV had no potent inhibitory activity in the replication of herpes simplex virus-1 or human cytomegalovirus. These observations suggest that BV could interact with MT-4 cells to inhibit an early stage of HHV-6 infection in a virus-specific manner. FAU - Nakagami, T AU - Nakagami T AD - Department of Virology, Osaka University, Japan. FAU - Taji, S AU - Taji S FAU - Takahashi, M AU - Takahashi M FAU - Yamanishi, K AU - Yamanishi K LA - eng PT - Journal Article PL - Australia TA - Microbiol Immunol JT - Microbiology and immunology JID - 7703966 RN - 1856-98-0 (Urobilin) RN - O9MIA842K9 (Biliverdine) RN - RFM9X3LJ49 (Bilirubin) SB - IM MH - Animals MH - Bilirubin/pharmacology/toxicity MH - Biliverdine/*pharmacology/toxicity MH - Dose-Response Relationship, Drug MH - Evaluation Studies as Topic MH - Herpesviridae Infections/*drug therapy MH - Herpesvirus 6, Human/*drug effects MH - Humans MH - Urobilin/pharmacology/toxicity EDAT- 1992/01/01 00:00 MHDA- 1992/01/01 00:01 CRDT- 1992/01/01 00:00 PHST- 1992/01/01 00:00 [pubmed] PHST- 1992/01/01 00:01 [medline] PHST- 1992/01/01 00:00 [entrez] AID - 10.1111/j.1348-0421.1992.tb02037.x [doi] PST - ppublish SO - Microbiol Immunol. 1992;36(4):381-90. doi: 10.1111/j.1348-0421.1992.tb02037.x.